GoodRx Holdings, Inc. GDRX
GoodRx Holdings, Inc. statistics & valuation
Market cap$948.3M
P / E31.2×
P / S1.2×
P / B1.5×
P / FCF5.8×
Net margin3.8%
Return on equity4.9%
FCF margin20.6%
Net debt$233.2M
Net debt / EBITDA1.4×
Enterprise value USD$1.2B
EV / EBITDA6.8×
Earnings yield EBIT/EV7.4%
Return on capital7.6%
Graham number -47.9%$1.87
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports. The Graham number is Benjamin Graham's rough maximum fair value ($1.87); a green figure means the price is below it.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Operating margin | 11.0% | 8.3% | -3.6% | 0.2% | 1.8% | -50.1% | 36.0% |
| Net margin | 3.8% | 2.1% | -1.2% | -4.3% | -3.4% | -53.3% | 17.0% |
| FCF margin | 20.6% | 23.1% | 18.3% | 18.6% | 23.4% | 20.1% | 21.1% |
| Return on assets | 2.2% | 1.2% | -0.6% | -2.0% | -1.6% | -20.0% | 17.1% |
| Return on equity | 4.9% | 2.3% | -1.2% | -4.0% | -3.0% | -41.3% | -6.1% |
| Debt / equity | 0.80× | 0.69× | 0.85× | 0.82× | 0.81× | 0.96× | -0.62× |
| Current ratio | 2.61 | 5.32 | 7.12 | 12.05 | 13.42 | 18.24 | 2.59 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.